Loratadine; Pseudoephedrine Sulfate

Drug Usage Statistics, United States, 2005 - 2015

Number of Prescriptions Over Time (2005 - 2015)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2004 666 -
2005 500  166
2006 231  269
2007 540  309
2008 497  43
2009 253  244
Year Rank Change
2010 342  89
2011 261  81
2012 378  117
2013 288  90
2014 229  59
2015 261  32

Patient Out-Of-Pocket Cost Over Time (2005 - 2015)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Claritin-d
  • Claritin-d 24 Hour
  • Loratadine And Pseudoephedrine Sulfate
Generic Drug Synonyms and Salts
  • Pseudoephedrine Sulfate; Loratadine
  • Loratadine; Pseudoephedrine Sulfate

FDA Approval Information

Established Pharmacologic Class (EPC): N/A
Initial FDA approval date: 11/27/2002
First FDA applicant: Otc
First dosage form: Tablet, Extended Release (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2005-2015. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 18.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

Easily learn drug therapy with our high-yield videos. The Top 250 Drugs by ClinCalc Academy
©2018 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Mar 4, 2017
Back to Top
Top